The University of Kansas Hospital/The Burnett Burn Center
Welcome,         Profile    Billing    Logout  
 6 Trials 
4 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Howard, James
NCT04833894 / 2020-005841-18: Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children with Generalized Myasthenia Gravis

Recruiting
2/3
12
Europe, Canada, US, RoW
Efgartigimod IV
argenx
Generalized Myasthenia Gravis
03/27
03/27
NCT04146051: Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Recruiting
2
30
Canada, US
Descartes-08
Cartesian Therapeutics
Myasthenia Gravis, Generalized
03/25
03/26
CATALYSTEM, NCT06564636: A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew ™ Primary Hip System

Enrolling by invitation
N/A
198
Canada, US
CATALYSTEM
Smith & Nephew, Inc.
Total Hip Arthroplasty (THA), Osteoarthritis, Degenerative Joint Disease, Inflammatory Arthritis, Avascular Necrosis, Post-traumatic Arthritis, Congenital Hip Dysplasia
12/26
02/30
NCT04879732: RSA - ACTIS Hip Stem

Active, not recruiting
N/A
64
Canada
ACTIS
Canadian Radiostereometric Analysis Network, DePuy Synthes
Hip Osteoarthritis
12/24
12/24

Download Options